| 1 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.31% |
| 2 | GH | Guardant Health, Inc. | 5.24% |
| 3 | ILMN | Illumina, Inc. | 5.24% |
| 4 | PRAX | Praxis Precision Medicines, Inc. | 4.93% |
| 5 | NTRA | Natera, Inc. | 4.46% |
| 6 | MRNA | Moderna, Inc. | 4.34% |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 3.93% |
| 8 | BMRN | BioMarin Pharmaceutical Inc. | 3.82% |
| 9 | RNA | Avidity Biosciences, Inc. | 3.78% |
| 10 | TECH | Bio-Techne Corporation | 3.62% |
| 11 | QGEN | Qiagen N.V. | 3.57% |
| 12 | WGS | GeneDx Holdings Corp. | 3.47% |
| 13 | BNTX | BioNTech SE | 3.42% |
| 14 | CRSP | CRISPR Therapeutics AG | 3.40% |
| 15 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.10% |
| 16 | VCYT | Veracyte, Inc. | 2.88% |
| 17 | RARE | Ultragenyx Pharmaceutical Inc. | 2.79% |
| 18 | LEGN | Legend Biotech Corporation | 2.68% |
| 19 | LLY | Eli Lilly and Company | 2.25% |
| 20 | WVE | Wave Life Sciences Ltd. | 2.22% |
| 21 | BMY | Bristol-Myers Squibb Company | 2.22% |
| 22 | BEAM | Beam Therapeutics Inc. | 2.16% |
| 23 | LON: AZN | AstraZeneca PLC | 2.00% |
| 24 | GILD | Gilead Sciences, Inc. | 1.89% |
| 25 | SRPT | Sarepta Therapeutics, Inc. | 1.77% |
| View GNOM holdings |
